Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR
- PMID: 35895233
- DOI: 10.1007/s10620-022-07623-4
Individualization of HCC and Portal Hypertension Surveillance in Patients with Compensated Advanced Chronic Liver Disease and SVR
Comment on
-
Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.Dig Dis Sci. 2023 Jan;68(1):323-332. doi: 10.1007/s10620-022-07621-6. Epub 2022 Jul 27. Dig Dis Sci. 2023. PMID: 35895234
Similar articles
-
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules.J Hepatol. 2022 Apr;76(4):874-882. doi: 10.1016/j.jhep.2021.11.023. Epub 2021 Nov 29. J Hepatol. 2022. PMID: 34856322
-
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease.J Hepatol. 2022 Apr;76(4):812-821. doi: 10.1016/j.jhep.2021.11.025. Epub 2021 Dec 3. J Hepatol. 2022. PMID: 34871626
-
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.J Hepatol. 2020 Mar;72(3):472-480. doi: 10.1016/j.jhep.2019.10.005. Epub 2019 Oct 17. J Hepatol. 2020. PMID: 31629779
-
Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?World J Gastroenterol. 2021 Oct 28;27(40):6737-6749. doi: 10.3748/wjg.v27.i40.6737. World J Gastroenterol. 2021. PMID: 34790004 Free PMC article. Review.
-
Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?Liver Int. 2016 Jun;36(6):783-90. doi: 10.1111/liv.13106. Epub 2016 Mar 24. Liver Int. 2016. PMID: 26936383 Review.
References
-
- Mandorfer M, Kozbial K, Freissmuth C, Schwabl P, Stattermayer AF, Reiberger T et al. Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses. Aliment Pharmacol Ther. 2015;42:707–718. - DOI
-
- Mandorfer M, Kozbial K, Schwabl P, Chromy D, Semmler G, Stattermayer AF et al. Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy. Hepatology. 2020;71:1023–1036. - DOI
-
- Lens S, Baiges A, Alvarado-Tapias E, E LL, Martinez J, Fortea JI, et al. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension. J Hepatol. 2020;73(6):1415–24.
-
- Mandorfer M, Simbrunner B. Prevention of First Decompensation in Advanced Chronic Liver Disease. Clin Liver Dis. 2021;25:291–310. - DOI
-
- de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959–974.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical